CRSP
#1287
CRISPR Therapeutics AG - Common Shares
56.9 8 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.28%
Variación mensual
+18.61%
Variación en los últimos 6 meses
-1.83%
Cambio anual
+11.73%
Cierres anteriores
57.7 2
Open
56.9 2
Mínimo
56.9 2
Máximo
56.9 8
Volumen
157
Financials
- Market Capitalization 5.51 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-11.58
Relación precio/flujo de caja
389.54
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1251 |  PTCT PTC Therapeutics, Inc. - Common Stock | 69.54 USD | -0.78% | -3.00% | +3.51% | +40.57% | 5.80 B USD | ||
| 1277 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 281.99 USD | +0.53% | -0.23% | -1.79% | +50.70% | 5.62 B USD | ||
| 1294 |  DFTX Definium Therapeutics, Inc. - Common Shares | 39.45 USD | -3.73% | -10.26% | -7.98% | +161.09% | 5.30 B USD | ||
| 1350 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 28.91 USD | -0.69% | -3.60% | +11.32% | +11.58% | 4.98 B USD |